Glucametacin

Glucametacin

SCHEMBL24511

COc1ccc2c(c1)c(CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO)c(C)n2C(=O)c1ccc(Cl)cc1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 20/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glucametacin SCHEMBL30344903 1.00 PTGS2 (0.72) PTGS2
Glucametacin SCHEMBL27641193 1.00 PTGS2 (0.72) PTGS2
Glucametacin SCHEMBL5081097 1.00 PTGS2 (0.72) PTGS2
Glucametacin SCHEMBL9988209 0.91 PTGS2 (0.63) PTGS2
Indomethacin SCHEMBL8509782 0.86 PTGS2 (0.74) PTGS2
SCHEMBL5080287 0.86 PLA2G2A (0.65) PTGS2
SCHEMBL5080284 0.86 PLA2G2A (0.65) PTGS2
SCHEMBL27599208 0.86 PTGS2 (0.62) PTGS2
SCHEMBL11263049 0.85 PTGS2 (0.74) PTGS2
SCHEMBL11263058 0.84 PTGS2 (0.67) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3434 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240041935-A1 PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS CREATIVE MEDICAL TECHNOLOGIES, INC. (US) 2024-02-08 US claimed
WO-2024013415-A1 USE OF CURRENTS, METHOD AND DEVICE FOR ANALYSING A 4WD TRANSFORMER UNIVERSITAT POLITÈCNICA DE VALÈNCIA (ES) 2024-01-18 WO claimed
WO-2023139300-A1 METHOD FOR MAINTAINING THE MAGNETIC FIELD OF THREE-PHASE INDUCTION MACHINES UNDER GRID VOLTAGE DISTURBANCES UNIVERSITAT POLITECNICA DE VALENCIA (ES) 2023-07-27 WO claimed
EP-4034087-A1 LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS DDS Research Inc. (CA) 2022-08-03 EP claimed
US-20220218611-A1 LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS DDS RESEARCH INC. (CA) 2022-07-14 US claimed
US-20210145763-A1 LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE EYE CO PTY LTD. (AU) 2021-05-20 US claimed
WO-2021056106-A1 LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS DDS RESEARCH INC. (CA) 2021-04-01 WO claimed
EP-3773651-A1 LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE Eye Co Pty Ltd. (AU) 2021-02-17 EP claimed
WO-2019191800-A1 LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE EYE CO PTY LTD (AU) 2019-10-10 WO claimed
US-20180111944-A1 (R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE TECNIMEDE SOCIEDADE TECNICO-MEDICINAL S.A. (PT) 2018-04-26 US claimed
EP-0759750-A1 COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES SHAPIRO, Howard, K. (US) 1997-03-05 EP claimed
US-5543417-A 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent MERCK & CO., INC. (US) 1996-08-06 US claimed
WO-1996012487-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed
WO-1996012817-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed
WO-1995031194-A1 COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES SHAPIRO HOWARD K (US) 1995-11-23 WO claimed
WO-1993004280-A1 GRAVITY/FLOTATION MOTOR VALCOURT Y CABRAL HENRI ROBERT (ES) 1993-03-04 WO claimed
EP-0249561-B1 COMPOSITIONS USING LIPOSOME-ENCAPSULATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS THE LIPOSOME COMPANY, INC. (US) 1992-05-13 EP claimed
WO-1987007506-A1 METHODS AND COMPOSITIONS USING LIPOSOME-ENCAPSULATED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS THE LIPOSOME COMPANY, INC. (US) 1987-12-17 WO claimed
EP-0249561-A2 Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs THE LIPOSOME COMPANY, INC. (US) 1987-12-16 EP claimed
US-4332795-A INDOLE COMPOUND AND PHOSPHOLIPID A. NATTERMANN & CIE. GMBH (DE) 1982-06-01 US claimed